论文部分内容阅读
目的:探讨蚌埠市农村已婚妇女乳腺疾病的患病率及其影响因素,为有针对性地开展乳腺疾病防治工作提供基础数据。方法:采用分层整群抽样法选取3 089例已婚妇女,采用先集中和后入户的调查方式进行乳腺疾病相关问卷调查。3 089例已婚妇女均接受乳腺检查,内容包括临床体检和乳腺红外线检查。结果:农村已婚妇女乳腺疾病的患病率为13.3%,前3种乳腺疾病分别为乳腺增生、纤维腺瘤和乳腺炎性疾病,其患病率分别为12.9%、0.3%和0.1%。多因素Logistic回归分析显示:相对于初中及以上文化程度妇女,无痛经,无引产、流产史的农村已婚育龄妇女,小学以下文化程度妇女,有痛经,有引产、流产史的妇女罹患乳腺疾病的危险度增高;与年龄≤29岁、月经周期≤24天、月经量少、家庭年均收入≤5 000元的农村已婚育龄妇女相比,年龄大、月经周期时间长、月经量多、家庭年均收入高的妇女罹患乳腺疾病的危险度增加。结论:农村已婚妇女乳腺疾病发生率较高,且受多种因素影响。应坚持定期防癌普查,加强乳腺疾病的二级预防。
Objective: To investigate the prevalence and influencing factors of breast disease in rural married women in Bengbu City, and to provide the basic data for the targeted prevention and treatment of breast disease. Methods: A total of 3 089 married women were selected by stratified cluster sampling method, and questionnaires about breast diseases were collected by using the first concentration and later households survey methods. 3 089 married women underwent breast examinations, including clinical examination and breast IR examination. Results: The prevalence of breast disease in rural married women was 13.3%. The first three kinds of breast diseases were hyperplasia of mammary gland, fibroadenoma and mastitis disease, the prevalence rates were 12.9%, 0.3% and 0.1% respectively. Multivariate Logistic regression analysis showed that: compared with women of junior high school education and above, married women of childbearing age, no history of induced abortion and miscarriage in rural areas, women of educational level of primary school, women with dysmenorrhea, induced abortion and abortion had breast disease Compared with the married women of childbearing age in rural areas who were ≤29 years of age, menstrual cycle ≤24 days, less menstruation and family annual income was less than or equal to 5,000 yuan, the age, menstrual cycle, Women with high annual household income are at an increased risk of breast disease. Conclusion: The incidence of breast disease in rural married women is high and affected by many factors. Should adhere to regular census of cancer, and strengthen secondary prevention of breast disease.